Phospholipid-modified polyethylenimine-based nanopreparations for siRNA–mediated gene silencing: Implications for transfection and the role of lipid components
- 28 February 2014
- journal article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 10 (2), 411-419
- https://doi.org/10.1016/j.nano.2013.07.016
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene deliveryBiomaterials, 2012
- Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membraneProceedings of the National Academy of Sciences of the United States of America, 2012
- P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cellsNanomedicine, 2012
- Lipid substitution on low molecular weight (0.6–2.0kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expressionActa Biomaterialia, 2011
- Revisit complexation between DNA and polyethylenimine — Effect of length of free polycationic chains on gene transfectionJournal of Controlled Release, 2011
- Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA deliveryDrug Delivery and Translational Research, 2010
- Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic deliveryJournal of Controlled Release, 2010
- The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA deliveryThe Journal of Gene Medicine, 2010
- Self-assembling micelle-like nanoparticles based on phospholipid–polyethyleneimine conjugates for systemic gene deliveryJournal of Controlled Release, 2009
- Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administrationInternational Journal of Pharmaceutics, 2007